Today's Daily Dose brings you news about Puma Biotech's SUMMIT basket trial results; TransEnterix' reverse stock split; Seattle Genetics' pivotal HER2CLIMB study and the latest update on Intec/Novartis deal.
from RTT - Biotech https://ift.tt/2qFycs2
via IFTTT
No comments:
Post a Comment